Literature DB >> 5392898

Preparation of La Crosse virus hemagglutinating antigen in BHK-21 suspension cell cultures.

W A Chappell, P E Halonen, R F Toole, C H Calisher, L Chester.   

Abstract

Hemagglutinating and complement-fixing antigens of La Crosse virus (California arbovirus group) were produced in serum-free suspension cultures of BHK-21/13S cells. The appearance and production of these antigens were correlated with the titer of infectious virus. No significant differences in antigen titers were produced by varying virus dose 10-fold. Hemagglutinin appeared 6 to 8 hr after inoculation and reached peak titer in 14 to 22 hr. Both beta-propiolactone and Tween 80-ether treatment inactivated infectious virus in the antigens. Unlyophilized antigen was stable at -60, 5 and 24 C for at least 117 days but not for 1 year. Lyophilized antigen was stable for at least a year, however, at -20 and 5 C. Cell culture-produced antigen was more sensitive than brain-produced antigen in detecting hemagglutination inhibition antibody in human sera.

Entities:  

Mesh:

Substances:

Year:  1969        PMID: 5392898      PMCID: PMC377999          DOI: 10.1128/am.18.3.433-437.1969

Source DB:  PubMed          Journal:  Appl Microbiol        ISSN: 0003-6919


  14 in total

1.  Techniques for hemagglutination and hemagglutination-inhibition with arthropod-borne viruses.

Authors:  D H CLARKE; J CASALS
Journal:  Am J Trop Med Hyg       Date:  1958-09       Impact factor: 2.345

2.  Rubella hemagglutinin prepared in serum free suspension culture of BHK-21 cells.

Authors:  P E Halonen; J A Stewart; A D Hall
Journal:  Ann Med Exp Biol Fenn       Date:  1967

Review 3.  History and recent reappearance of viruses in the California encephalitis group.

Authors:  W M Hammon; G Sather
Journal:  Am J Trop Med Hyg       Date:  1966-03       Impact factor: 2.345

4.  California group arboviruses: immunodiffusion studies.

Authors:  F A Murphy; P H Coleman
Journal:  J Immunol       Date:  1967-08       Impact factor: 5.422

5.  Hemagglutinin of rabies and some other bullet-shaped viruses.

Authors:  P E Halonen; F A Murphy; B N Fields; D R Reese
Journal:  Proc Soc Exp Biol Med       Date:  1968-04

6.  California group arboviruses: electron microscopic studies.

Authors:  F A Murphy; S G Whitfield; P H Coleman; C H Calisher; E R Rabin; A B Jenson; J L Melnick; M R Edwards; E Whitney
Journal:  Exp Mol Pathol       Date:  1968-08       Impact factor: 3.362

7.  Antigenic patterns within the California-encephalitis-virus group.

Authors:  G E Sather; W M Hammon
Journal:  Am J Trop Med Hyg       Date:  1967-07       Impact factor: 2.345

8.  Rubella complement fixing antigen prepared by alkaline extraction of virus grown in suspension culture of BHK-211 cells.

Authors:  P D Halonen; H L Casey; J A Stewart; A D Hall
Journal:  Proc Soc Exp Biol Med       Date:  1967-05

9.  The use of adjuvant and sarcoma 180 cells in the production of mouse hyperimmune ascitic fluids to arboviruses.

Authors:  E S Tikasingh; L Spence; W G Downs
Journal:  Am J Trop Med Hyg       Date:  1966-03       Impact factor: 2.345

10.  California encephalitis virus, a newly described agent.

Authors:  W M HAMMON; W C REEVES
Journal:  Calif Med       Date:  1952-11
View more
  9 in total

1.  Serum dilution neutralization test for California group virus identification and serology.

Authors:  H S Lindsey; C H Calisher; J H Mathews
Journal:  J Clin Microbiol       Date:  1976-12       Impact factor: 5.948

2.  Salt-dependent hemagglutination with Bunyaviridae antigens.

Authors:  B J Beaty; R E Shope; D H Clarke
Journal:  J Clin Microbiol       Date:  1977-05       Impact factor: 5.948

3.  La Crosse virus soluble cell culture antigen.

Authors:  H S Lindsey; R A Klimas; J F Obijeski
Journal:  J Clin Microbiol       Date:  1977-12       Impact factor: 5.948

4.  Production of hemagglutinating of La Crosse virus by polyethylene glycol precipitation.

Authors:  M Rabson; B J Beaty; S W Hildreth; R E Shope
Journal:  J Clin Microbiol       Date:  1981-03       Impact factor: 5.948

5.  Comparison of methods for removal of nonspecific inhibitors of arbovirus hemagglutination.

Authors:  T P Monath; H S Lindsey; J G Nuckolls; W A Chappell; B E Henderson
Journal:  Appl Microbiol       Date:  1970-11

6.  Indirect fluorescent-antibody technique for serological diagnosis of La Crosse (California) virus infections.

Authors:  B J Beaty; J Casals; K L Brown; C B Gundersen; D Nelson; J T McPherson; W H Thompson
Journal:  J Clin Microbiol       Date:  1982-03       Impact factor: 5.948

7.  Production and use of a hemagglutinin for detecting antibody to Jamestown Canyon virus.

Authors:  P R Grimstad; H Artsob; N Karabatsos; C H Calisher
Journal:  J Clin Microbiol       Date:  1987-08       Impact factor: 5.948

8.  Serodiagnosis of La Crosse virus infections in humans by detection of immunoglobulin M class antibodies.

Authors:  C H Calisher; C I Pretzman; D J Muth; M A Parsons; E D Peterson
Journal:  J Clin Microbiol       Date:  1986-04       Impact factor: 5.948

9.  La Crosse virus: a scoping review of the global evidence.

Authors:  S Harding; J Greig; M Mascarenhas; I Young; L A Waddell
Journal:  Epidemiol Infect       Date:  2018-12-05       Impact factor: 2.451

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.